Proxima™ patient-dedicated blood gas analysis monitoring system to be exhibited on Sphere Medical’s stand (#8) 

The Proxima™ patient dedicated in-line blood gas monitoring system in an intensive care unit 


Sphere Medical, an innovative company in critical care monitoring and diagnostics equipment, will be exhibiting its novel Proxima™ patient dedicated in-line blood gas monitoring system at the forthcoming British Association of Critical Care Nurses (BACCN) 31st annual conference. In addition to appearing on Sphere’s stand (#8), Proxima has also been selected to feature in the BACCN’s Simulation Lab sessions. At the conference, which takes place in Glasgow on 19-20th September 2016, critical care professionals from across the UK will come together to discuss, share and debate best practice, research and issues from across the critical care field. 



Proxima is the first generation of a new class of products that will redefine how arterial blood gas testing is carried out on critically ill patients and has the potential to become the standard of care, supporting rapid and frequent measurement without leaving the patient’s bedside. Proxima has been recognised by BACCN Chair, Annette Richardson, as an innovation that critical care nurses should be aware of in her annual conference opening session in 2014. This was also published in the Association’s journal, Nursing in Critical Care [1]. This year Proxima has been selected to feature in the BACCN conference’s Simulation Lab sessions where scenarios such as ‘How a Tracheostomy Simulation was used to recruit Senior ICU Staff’ will be presented and debriefed.

 

Also at the BACCN conference, demonstrating the effectiveness of the closed blood gas monitoring system, results of a recent hospital-based time and motion study using Proxima will be presented. In conjunction with University Hospital Southampton, Sphere has conducted a time and motion study to investigate the workflow impacts of Proxima in a cardiac intensive care unit. Following the completion of data collection, initial analysis indicates that Proxima reduces the time to results and time away from the patient. Full data analysis and results will be presented as a poster at the conference.

 

“We are extremely pleased with the recognition of the innovation and value of Proxima for the close monitoring of critically ill patients. By measuring blood gas parameters in the patient’s bed space, the care giver can stay right by the patient to enable timely interventions and closer clinical management,” said Gavin Troughton, VP Business Development, Sphere Medical. “We are also excited to be able to preview the next generation Proxima on our stand at the BACCN conference, which we plan to launch by the end of this year.”

 

For more information on the Proxima™ in-line blood gas analyser, please view www.spheremedical.com/products/proxima or visit Sphere Medical’s stand (#8) at the 31st Annual BACCN conference 2016.



Reference:

  1. Richardson, A. (2015), Frontline leadership, innovation and best practice: 10 hot topics every critical care nurse should be aware of. Nurs Crit Care, 20: 3–4. doi:10.1111/nicc.12153

Source & Image Credit: Sphere Medical


«« Study: Four Predictors Indicate Mortality Risk in Elderly Patients


Critical Illness Leads to Significant, Rapid Dysbiosis »»



Latest Articles

BACCN,Simulation Lab , Critical Care, Sphere Medical, Blood gas analysis Sphere Medical, an innovative company in critical care monitoring and diagnostics equipment, will be exhibiting its novel Proxima™ patient dedicated in-line blood gas monitoring system at the forthcoming British Association of Critical Care Nurses (BACCN)